A Retrospective Analysis of BCR-ABL1 Kinase Domain Mutations in the Frontline Drug Intolerant or Resistant Chronic Myeloid Leukemia Patients: An Indian Experience from a High-End Referral Laboratory - Majumdar, Atreye; Katara, Rahul; Mishra, Avshesh; Gupta, Aastha; Sharma, Deepak K.; Srivastava, Aman K.; Sharma, Shivani; Jaiswal, Ankita; Dixit, Mallika; Kumar, Vipin; Kumar, Sachin; Kumar, Varun; et al. (South Asian journal of cancer, 2024)
Keywords: BCR-ABL1; chronic myeloid leukemia; kinase domain mutations; Original; Sanger sequencing; therapy resistance; tyrosine kinase inhibitors; tyrosine kinase inhibitors; chronic myeloid leukemia; Sanger sequencing; kinase domain mutations; BCR-ABL1; therapy resistance